...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trial

THOUGHT the results would have been published by now.Did I miss them Bear

1
Dec 10, 2019 09:20PM
3
Feb 09, 2020 10:02AM
3
Feb 09, 2020 11:00AM
5
Feb 13, 2020 02:57PM
Share
New Message
Please login to post a reply